Approving new drugs
Science
.
2017 Feb 24;355(6327):777.
doi: 10.1126/science.aam9914.
Author
John L LaMattina
1
Affiliation
1
John L. LaMattina is a senior partner at PureTech Health and the former president of Pfizer Global Research and Development. john.lamattina@comcast.net.
PMID:
28232527
DOI:
10.1126/science.aam9914
No abstract available
Publication types
Editorial
MeSH terms
Clinical Trials as Topic
Drug Approval*
Humans
Safety
United States
United States Food and Drug Administration